key: cord-0912804-a2xmgcek
authors: Li, Hongmei; Liu, Ting; Wang, Liping; Wang, Minghui; Wang, Shaoqing
title: SARS‐CoV‐2 Delta variant infects ACE2(low) primary human bronchial epithelial cells more efficiently than other variants
date: 2021-10-08
journal: J Med Virol
DOI: 10.1002/jmv.27372
sha: 888ab815c0fc38be7a8c902fc4e793e8d878604b
doc_id: 912804
cord_uid: a2xmgcek

SARS-CoV-2 Delta variant has become the predominant circulating variant around the globe. Here we report that the Delta variant Spike protein appears to confer greater infectivity on primary human airway cells in which only low levels of ACE2 are found. Our data suggests that the Delta variant virus may be able to infect cells lining the respiratory tract in individuals even when there is very little ACE2. This finding sheds important light to understanding why Delta variant exhibits greater transmissibility and became the predominant circulating SARS-CoV-2 variant in the world. This article is protected by copyright. All rights reserved.

To the Editor,

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) has drastically altered the landscape of the coronavirus disease 2019 (COVID-19) pandemic. 1 Despite a reported two-to-three-fold reduction in neutralizing antibody titers against the Delta variant in vaccinees, 2, 3 breakthrough infections are frequently noticed, 4 raising the possibility that the Delta variant has evolved mechanisms other than escaping from vaccine-or natural infection-induced immunity to become the dominant variant around the globe. 5 In consistence, experimental data do not predict the mutations found in the Delta variant spike protein to confer the highest affinity toward its receptor, 6 the human angiotensin-converting enzyme 2 (ACE2). Several studies of the Delta variant spike suggest that the P681R mutation at the furin cleavage site may enhance the proteolytic processing of the protein and hence renders unique features to the variant during entry. [7] [8] [9] Here, we conducted a study to investigate the relationship between ACE2 expression levels on human airway way cells and the F I G U R E 1 Pseudovirus bearing Delta variant spike protein infects ACE2 low HBEpC to a higher level than other variants. HBEpC from 12 different donors were measured for surface expression of ACE2 by flow cytometric analysis and plotted on the x-axis from low to high. The corresponding infectivities of an equal amount of pseudoviruses bearing the original Wuhan-Hu-1, Alpha, Beta, Gamma, and Delta variant spike protein on cells from each donor are plotted on the y-axis. Statistical analysis was performed using two-way ANOVA, *p < 0. 05, **p < 0.01, ***p < 0.001

Interim estimates of increased transmissibility, growth rate, and reproduction number of the Covid-19 B.1.617.2 variant of concern in the United Kingdom. medRxiv

Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston

New SARS-CoV-2 variants have changed the pandemic. What will the virus do next

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin

SARS-CoV-2 spike P681R mutation, a hallmark of the Delta variant, enhances viral fusogenicity and pathogenicity

The innate immune function of airway epithelial cells in inflammatory lung disease

Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern